Massive 8,000-Patient study tracks rare blood cancers for decades
NCT ID NCT02863692
Summary
This study is creating a long-term registry to track 8,000 patients with several rare types of leukemia and lymphoma. It aims to collect health information over many years to understand how these diseases progress, how treatments affect long-term survival, and what late side effects might occur. The goal is to gather real-world data to help improve future care for these rare conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
BAG Freiberg-Richter, Jacobasch, Wolf, Illmer
RECRUITINGDresden, Saxony, Germany
Contact
Conditions
Explore the condition pages connected to this study.